It has been recently revealed that the second largest private medical insurance company in the UK has changed its opinion on Abiraterone, a drug used to treat patients suffering from advanced prostate cancer.

The competition among life insurance companies is very violent, as the emerging companies are selling simple term life products direct and online.

Friends Provident, Axa Life and Bupa Health Insurance, have seen a rapid growth in their progress and greater investor confidence in the foreign countries.

The Australian Competition & Consumer Commission are said to have blocked NAB's high cash or scrip proffer for the Company, following which AXA SA which is APH's French parent has out forth an invitation for the bidders.

As investors concluded that Harvey McGrath and Tidjane Thiam, Chairman and Chief Executive, were essentially not acting in shareholders' interests, Prudential's management faced extensive instability at their proposed $35.5bn possession of AIA.

French insurer AXA confirmed that it was bearing in mind a £2.75m sale of its British life and pensions business to Friends Provident owner Resolution, as a consequence, shares in Clive Cowdery's acquisition vehicle Resolution have been suspended.

AXA will be selling the 16% stake it holds in Taikang, a leading Chinese insurer, and Singapore based investment firm Temasek is all set to send in a bid to acquire the same. Although there are a few bidders for the stake, AXA has said it will consider each bid very carefully before making a decision.

Despite reporting a fall in the sales figures collected for the first nine months of the year, one of Europe's top ranked insurance firm, AXA said that market conditions were definitely improving, and the business environment was turning around steadily.